Where Pinealon comes from

To understand Pinealon you need to know a little about the research network behind it. Its story is closely tied to one scientist and one city.

A school of short-peptide research

Professor Vladimir Khavinson and his colleagues in St Petersburg spent decades on the idea that tiny peptides can help regulate the tissues they are linked to. Their institute, devoted to bioregulation and gerontology, developed a whole range of two-, three- and four-amino-acid peptides, each associated with a particular organ. Pinealon is one of the tripeptides from that collection.

A name that misleads

The name suggests the pineal gland, the small structure deep in the brain that makes melatonin. In the published research, however, Pinealon is studied almost entirely for its possible effects on nerve cells in general: the cortex, the cerebellum and the hippocampus. So it is better thought of as a brain-cell research peptide than as a pineal one.

First lab reports

Early papers, many of them in the Russian-language journal Advances in Gerontology, tested several short peptides in models of low oxygen and stress. Around 2011 the group published English-language work showing that Pinealon lowered levels of harmful oxygen by-products in nerve and immune cells and kept more of them alive. The same year, a related study used fluorescent labels to show that such short peptides can enter human cells and their nuclei.

Animal studies

In 2012 a team reported that giving Pinealon to pregnant rats with a diet-induced chemical imbalance led to offspring that learned better and had sturdier brain cells than untreated offspring. Later Russian studies looked at older rats exposed to thin air or cold.

The Alzheimer's angle

From 2017 onwards, the work turned towards models of Alzheimer's disease. Researchers reported that Pinealon helped mouse neurons keep their mushroom-shaped spines, the contact points for memory-related signalling, when exposed to a toxic protein fragment. A 2024 study used nerve cells made from the skin cells of elderly donors and again saw more branching. Computer modelling papers tried to explain these effects by peptide binding to DNA.

Timeline at a glance

• Decades before: the St Petersburg group builds a library of short peptides.
• 2008: Russian-language papers test short peptides in low-oxygen models.
• 2011: English-language cell studies on oxidative stress and on peptides entering the nucleus.
• 2012: rat offspring study; a small Russian report in professional drivers.
• 2014: work on serotonin-related genes in brain cortex cells.
• 2017–2021: neuron spine studies in Alzheimer's disease models.
• 2019–2023: physics and computer modelling of peptide–DNA binding and cell uptake.
• 2024: study in neurons grown from older people's skin cells.